What can we learn from hepatitis B virus clinical cohorts?
about
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score.
P2860
What can we learn from hepatitis B virus clinical cohorts?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
What can we learn from hepatitis B virus clinical cohorts?
@en
type
label
What can we learn from hepatitis B virus clinical cohorts?
@en
prefLabel
What can we learn from hepatitis B virus clinical cohorts?
@en
P2860
P356
P1433
P1476
What can we learn from hepatitis B virus clinical cohorts?
@en
P2093
Chih-Lin Lin
Tai-Chung Tseng
P2860
P356
10.1111/LIV.12716
P478
35 Suppl 1
P577
2015-01-01T00:00:00Z